|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.450 USD | -0.91% |
|
-4.98% | -5.79% |
| 05-14 | Clene Inc - Enters second amendment to senior secured convertible notes - SEC filing | RE |
| 05-14 | Clene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLENE INC. | Bio Therapeutic Drugs | +0.55% | -4.98% | -5.79% | +31.67% | -97.52% | 70.28M |  |  | |
- Stock Market
- Stocks
- CLNN Stock
- Charts Clene Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
